200 related articles for article (PubMed ID: 12227896)
21. Progesterone and endometrial cancer.
Gompel A
Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():95-107. PubMed ID: 32732107
[TBL] [Abstract][Full Text] [Related]
22. Progesterone, progestins and the breast in menopause treatment.
Gompel A; Plu-Bureau G
Climacteric; 2018 Aug; 21(4):326-332. PubMed ID: 29852797
[TBL] [Abstract][Full Text] [Related]
23. Biology of female sex hormone action in relation to contraceptive agents and neoplasia.
King RJ
Contraception; 1991 Jun; 43(6):527-42. PubMed ID: 1651204
[TBL] [Abstract][Full Text] [Related]
24. Exogenous progestagens and the human breast.
Sitruk-Ware R; Plu-Bureau G
Maturitas; 2004 Sep; 49(1):58-66. PubMed ID: 15351097
[TBL] [Abstract][Full Text] [Related]
25. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
[TBL] [Abstract][Full Text] [Related]
26. Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer.
Birrell SN; Butler LM; Harris JM; Buchanan G; Tilley WD
FASEB J; 2007 Aug; 21(10):2285-93. PubMed ID: 17413000
[TBL] [Abstract][Full Text] [Related]
27. [Estrogens and progestins in hormone replacement therapy in menopause].
La Vecchia C
Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
[TBL] [Abstract][Full Text] [Related]
28. [Effects of progesterone and progestational hormones on the mammary gland].
Gorins A; Denis C
Arch Anat Cytol Pathol; 1995; 43(1-2):28-35. PubMed ID: 7794024
[TBL] [Abstract][Full Text] [Related]
29. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
30. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
[TBL] [Abstract][Full Text] [Related]
31. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
[TBL] [Abstract][Full Text] [Related]
32. The estrogenic activity of synthetic progestins used in oral contraceptives.
Jordan VC; Jeng MH; Catherino WH; Parker CJ
Cancer; 1993 Feb; 71(4 Suppl):1501-5. PubMed ID: 8431886
[TBL] [Abstract][Full Text] [Related]
33. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women.
Archer DF
Menopause; 2001; 8(4):245-51. PubMed ID: 11449081
[TBL] [Abstract][Full Text] [Related]
34. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
Persson I; Yuen J; Bergkvist L; Schairer C
Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer and hormone replacement therapy: putting the risk into perspective.
Campagnoli C; Abbà C; Ambroggio S; Biglia N; Ponzone R
Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():53-60. PubMed ID: 12227887
[TBL] [Abstract][Full Text] [Related]
36. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis.
Asi N; Mohammed K; Haydour Q; Gionfriddo MR; Vargas OL; Prokop LJ; Faubion SS; Murad MH
Syst Rev; 2016 Jul; 5(1):121. PubMed ID: 27456847
[TBL] [Abstract][Full Text] [Related]
37. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement.
Persson I; Weiderpass E; Bergkvist L; Bergström R; Schairer C
Cancer Causes Control; 1999 Aug; 10(4):253-60. PubMed ID: 10482483
[TBL] [Abstract][Full Text] [Related]
38. Hormone replacement therapy and risk of breast cancer: the role of progestins.
Stahlberg C; Pederson AT; Lynge E; Ottesen B
Acta Obstet Gynecol Scand; 2003 Jul; 82(7):335-44. PubMed ID: 12790856
[TBL] [Abstract][Full Text] [Related]
39. Does HRT modify risk of gynecological cancers?
Schneider HP; Birkhauser M
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
[TBL] [Abstract][Full Text] [Related]
40. Estrogen-progestin replacement therapy and endometrial cancer.
Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
